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Abstract
Technical improvements in thyroid surgery are nearly close with the progress of the 
vessels sealing systems. In all cases, we need to obtain a radical and safe thyroid exci-
sion. This chapter is conducted to evaluate the technical key point and the postoperative 
benefits of our procedure using vessels sealing devices in differentiated thyroid cancers. 
A prospective study, carried out in First Surgical Clinic, Emergency County Clinical 
Hospital Tirgu Mureș, Romania from January 01, 2013 to March 01, 2018, based on 100 
consecutive patients, divided into two groups: first group without ligatures, using Small 
Jaw LigaSure™, and the second group operated by conventional procedure. Statistical 
analysis of some parameters (the thyroid pathology, operative time, hospitalization days, 
analgesic drugs, immediate postoperative complications and histopathological findings) 
shows that this procedure provides a total and “complete” removal of the thyroid speci-
men, with a decreased operative time and fewer hospitalization days.
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1. Introduction
Thyroid cancer represents approximately 3.8% of all new cancer cases having different genet-
ics, histogenesis and evolution, requiring specific management protocols and consensus [1]. 
Although a diagnosis of cancer is frightening, the vast majority of thyroid cancers is highly 
treatable and in most cases curable with a multidisciplinary treatment in which surgery plays 
an important role.
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In this chapter, we present the technical key points and postoperative benefits of the proce-
dure, using LigaSure™ small jaw in differentiated thyroid cancer.
2. Short history of thyroidectomy
During the twelfth and thirteenth century, there were many speculations regarding the role 
and the function of the thyroid gland and surgeries have been done according to them [2]. 
Roger Frugardi was first, in 1170, to describe the extirpation of the gland using setons, hot 
irons and caustic powder [3].
Evolution of thyroidectomy is related to the advances of the technology even though in the 
nineteenth century this procedure was considered “barbaric horrid butchery” (by S. Gross) 
[4]. Later on, in 1880, Jules Boeckel of Strasbourg introduced the collar incision to thyroid 
surgery, and this approach was popularized, later on, by Theodor Kocher.
The thyroidectomy (near or total), as we know it today, began in the 1860s with the help of 
Billroth [5]. Thyroid surgery was undertaken before the physiology was understood lead-
ing to complications, including massive hemorrhage, infection or injuries of the surrounding 
structures, which were associated with morbidity and mortality rates of about 40% [4].
In 1880, Sandstrom discovered the parathyroid glands but the fact that hypocalcemia was the 
definitive cause of tetany was not accepted until the twentieth century [6].
Later, in the nineteenth and the beginning of the twentieth centuries, Theodor Kocher prac-
ticed a meticulous thyroidectomy being able to report a mortality rate of 1%. He also described 
the “cachexia strumipriva” in patients following total thyroidectomy. For his contribution to 
thyroid pathology, Kocher received the Nobel Prize in 1909 [7, 8].
In 1920, the advances in thyroidectomy reached the peak making Halsted to refer to this sur-
gery as a “feat which today can be accomplished by any competent operator without danger 
of mishap” [1].
Nowadays, thyroid surgery can be performed with a low mortality as well as with low mor-
bidity. In order to obtain such results, surgeon must be aware of the pathophysiology of the 
thyroid disorders and must know very well the cervical anatomy.
3. Differentiated thyroid cancer
According to the American Cancer Society, differentiated thyroid cancer (DTC) derives from 
thyrocytes and expresses the sodium iodine symporter. DTC includes papillary, follicular and 
Hurthle cell cancer and represents most of thyroid cancer (90%).
3.1. Papillary cancer
About 80% of the patients diagnosed with thyroid cancers present the form of papillary car-
cinoma. This form of papillary cancer develops slowly, and it usually affects only one thyroid 
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lobe. With a slow growth, the papillary cancers often spread to the locally lymph nodes. Even 
it also affects the local lymph nodes, this cancer responds well to the treatment and is rarely 
fatal. There are several subtypes of papillary cancers, more than 10 histological variants which 
are documented and can be seen in Table 1 [9, 10].
3.2. Follicular cancer
Unlike the papillary form, the follicular cancer is the second most common thyroid cancer, 
affecting 10% of the persons diagnosed with thyroid cancer. It is more common in patients 
whose diet is poor in iodine. This type of cancer is characterized by the development of distant 
metastases, affecting organs such as the lungs and bones. The prognosis of this type of cancer 
varies depending on the degree of invasiveness. In the traditional classification of follicular 
thyroid cancer (FTC), there are two groups: minimally invasive and widely invasive [11–13].
3.3. Hurthle cell cancer
This type is also known as oxyphil cell carcinoma. About 3% of thyroid cancers are of this 
type. Most of the authors consider it as a form of follicular cancer [14].
4. Risk classification of DTC
The risk classification helps to predict the risk of local recurrence and developing metastases 
and the mortality in patients with DTC. It uses multiple staging systems which are based on a 
combination of the size of the primary tumor, specific histology, extrathyroidal spread of the 
tumor and the age at diagnosis.
The staging system most often used for thyroid cancer is the TNM (Table 2) system, which is 
based on three key pieces of information:
Papillary thyroid cancer Variants
Classic (usual)
Clear cell
Columnar cell
Cribriform-morular
Diffuse sclerosing
Follicular
Macrofollicular
Microcarcinoma (occult, latent, small, microtumor)
Solid
Tall cell
Warthin-like
Table 1. Variants of papillary thyroid cancer.
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• T = the size of the tumor
• N = the spread to the nearby lymph nodes
• M = the spread to distant sites (metastasis)
The most common risk classification is based on the tumor node metastasis (TNM) classification:
• very low-risk group: pT1a, cN0/pN0, cM02;
• low-risk group: pT1b, pT2, cN0/pN0, cM0;
• high-risk group: pT3, pT4, each N1, all M1.
TX: Primary tumor cannot be evaluated
T0: There is no evidence of primary tumor
T1: Tumor limited to the thyroid, whose maximum dimension does not exceed 2 cm
T1a: Tumor limited to the thyroid, whose greatest dimension does not exceed 1 cm
T1b: Tumor limited to the thyroid gland with dimension >1 cm, but lower than 2 cm in greatest dimension
T2: Tumor >2 cm but ≤4 cm in greatest dimension limited to the thyroid
T3: Tumor limited to the thyroid or with minimal extrathyroidal extension, with dimension <4 cm
T3a: Tumor dimension >4 cm but is limited to the thyroid
T3b: Minimal extrathyroidal extension invading the strap muscles (sternohyoid, sternothyroid, thyrohyoid or 
omohyoid muscles) from a tumor of any size
T4: Includes extrathyroidal extension into neck major structures
T4a: Tumor of any size with extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, 
esophagus or recurrent laryngeal nerve
T4b: Tumor of any size with extrathyroidal extension invading prevertebral fascia or encasing carotid artery or 
mediastinal vessels
NX: Regional lymph nodes cannot be evaluated
N0: There is no evidence of regional lymph node metastasis
N1: Metastasis to regional nodes
N1a: Unilateral or bilateral disease involving level VI or VII lymph nodes metastasis (pretracheal, paratracheal, 
prelaryngeal / Delphian or upper mediastinal)
N1b: Unilateral, bilateral or contralateral lymph nodes metastasis (levels I, II, III, IV or V) or retropharyngeal 
lymph nodes
M0: No distant metastasis
M1: Distant metastasis
Table 2. TNM classification, 8th edition [15].
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Based on the risk of structural disease recurrence, the American Thyroid Association defines 
in their current guideline the next classification [16]:
• high-risk group: gross extrathyroidal extension, incomplete tumor resection, distant metas-
tases, or lymph node >3 cm;
• intermediate-risk group: aggressive histology, minor extrathyroidal extension, vascular 
invasion, or >5 involved lymph nodes (0.2–3 cm);
• low-risk group: intrathyroidal DTC, ≤5 lymph nodes micrometastases (<0.2 cm)
The American Joint Committee on Cancer (AJCC) uses the combination of TNM classification 
and an age of more than 55 years at diagnosis as risk factor (Table 3).
5. Surgery without ligatures
Total complete thyroidectomy is the procedure that can be defined as an extracapsular thy-
roidectomy in which we remove the entire gland without remnant tissue.
5.1. Surgical instruments
The tool kit consists of a scalpel, Pean forceps (1–2 pieces), anatomical and surgical forceps, 
scissors, Farabeuf or Kocher spacers, monopolar cautery and LigaSure™ small jaw.
5.2. Incision
A 5–6 cm Kocher incision is performed in a flexion fold at 2–2.5 cm of the sternal notch. The 
skin, the subcutaneous cellular tissue and the platysma muscle are cut, after which a superior 
Age at diagnosis <55 years
Stage I: any T any N M0
Stage II: any T any N M1
Age at diagnosis ≥55 years
Stage I: T1 N0/NX M0
T2 N0/NX M0
Stage II: T1 N1 M0
T2 N1 M0
T3a/T3b any N M0
Stage III: T4a any N M0
Stage IVA: T4b any N M0
Stage IVB: any T any N M1
Table 3. Stage grouping according to AJCC.
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and a lower flap is made by dissection using LigaSure™ or electrocautery. The upper flap is 
suspended, exposing the white line (Figures 1–3).
5.3. How we do it
Penetration into the cleavage space by cutting the medial raf and releasing the anterior face 
of the anterior thyroide lobe. The thyroid lobe is mobilized with a thread (Figure 4).The dis-
section is continued laterally by sealing the middle thyroid vein with the LigaSure™ small 
Figure 3. Suspending the upper flap.
Figure 1. Kocher incision.
Figure 2. Preparing the upper and lower flap.
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jaw, then continuing cranially to the upper thyroid at the same time as the thyroid lobe 
dislocates (Figure 5).
Upper pole dissection with LigaSure™ Small Jaw, sealing the upper thyroid vascular pedicle 
(Figure 6).
The sealing of the lower branches of the lower thyroid pedicle is the essential time of this 
intervention, with the preservation of parathyroids, secondary branches of the inferior artery 
and the recurrent nerve. Dissection proceeds to the median line, sectioning Berry’s ligaments.
Figure 4. Traction of the thyroid lobe using thread.
Figure 5. Lateral dissection with the sealing of the medial vein.
Figure 6. Sealing the upper thyroid pedicle.
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Figure 7. Monobloc resection of the thyroid gland.
Lobectomy ends with the separation of the isthmus, being an optional time, or we can achieve 
a monobloc resection of the gland (Figure 7).
Control of the hemostasis, drainage of the thyroid cavity, intradermal resorbable suture.
6. Evaluation of the technique
6.1. Study description
In order to evaluate the feasibility of the technique, we conducted a prospective study which 
was carried out in Clinic of Surgery I, Emergency Clinical County Hospital Târgu Mureș from 
January 01, 2013 to June 01, 2017. The study enrolled 100 consecutive patients divided into two 
lots: 50 who underwent total complete thyroidectomy using LigaSure™ small jaw, including 
10 with “monobloc resection” and 50 in whom total thyroidectomy was performed by conven-
tional procedure (by using ligatures). The two groups were compared using statistical analy-
sis following the next parameters: the thyroid pathology, operative time, hospitalization days, 
analgesia used and immediate postoperative complications. Statistical analysis was performed 
employing Student’s test for comparison of the continuous variables. Differences between 
nonparametrical variables were compared using the Mann-Whitney U-test. Descriptive data 
were reported as the mean ± SD. The level of significance was set at p < 0.05.
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All patients have been prior diagnosed by fine needle aspiration (FNA) biopsy showing 
either papillary or follicular cancer.
All patients had preoperative and postoperative endocrinological consultations, and all the 
female patients had gynecological examination prior to the surgery.
6.2. Results
Extracapsular thyroidectomy was performed in all patients.
Surgery consisted of performing total thyroidectomy and double drainage of the thyroid 
compartment.
The two groups included in this study had similar demographics (age, sex) and the thyroid 
pathology also being the same (Table 4).
In the evaluation of the operative time measured from the moment of the skin incision 
to wound closure, we have found that statistical data followed a Gaussian distribution 
and it could be interpreted by Student’s t-test. The mean operative time in group 1 was 
73.81 ± 16.96 min, which is significantly less than the operative time in the second group 
(conventional) 106.19 ± 31.66 min (Table 5).
To appreciate the length of hospital stay, we applied the nonparametric Mann-Whitney test, 
since the two groups did not have a Gaussian distribution pattern, because of the value of 
17 days in group 1 and of 19 days in group 2. For group 1, the mean hospitalization time was 
of 4 days (range: 2–17 days), and for group 2, it was also 4 days (range: 3–19 days) (Table 6). 
We have not found statistically significant differences relating to these parameters of the 
patients in the two groups, regardless of the statistic method applied.
Group 1 Group 2
Mean age 54 52
Sex ratio F:M 45:5 43:7
Table 4. Patient’s demographic characteristics.
Minimum 45 65
Mean 73.81 106.19
Maximum 120 200
Median 72.5 100
Standard deviation 16.96 31.66
Table 5. Distribution of patients depending to the operative time.
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Group 1 Group 2
Minimum 2 2
Mean 4.09 4.61
Maximum 17.00 19.00
Median 3.00 4.00
Standard deviation 2.95 3.21
Table 6. Distribution of patients depending on length of hospitalization.
The evaluation of postoperative analgesia was performed by measuring the dose of analgesic 
drugs administered to each patient. The nonparametric Mann-Whitney test had been applied 
considering that the two groups did not have a Gaussian distribution (because of a maximal 
value of 17 days observed in the LigaSure-group and a maximal value of 19 days identified 
in the conventional group). The mean period of analgesia in group 1 was 2.5 days (range 
1–16 days), while in group 2, it was 3 days (range: 2–19 days). There was no statistically 
significant difference between the period of analgesic drug requirement in the two groups 
(p = 0.06).
No patients developed manifestations of hypocalcemia (hypoparathyroidism). There were 
few patients who experienced a change in voice (low pitched voice) seen in three patients from 
group 1 and in four patients in group 2. Hematoma was observed in two patients belonging to 
group 1 and in four patients belonging to group 2. There is no statistic significant difference 
between the incidence of early postoperative complications in the two groups (Table 7).
7. Discussion
Recently, thyroid surgery is considered quite safe, thanks to the proper surgical techniques 
that kept complications at a minimum rate (2–3%) [17].
The introduction of the new sealing devices in thyroid surgery benefits both patients and the 
surgeons. LigaSure™ small jaw is a proper device used to perform total complete thyroid-
ectomy, and it gives some technical advantages like: creates a clean surgical field providing 
better visibility, observed in other study [18]; no need to expose the vascular pedicles their 
dissection being possible using the device’s forceps; reduces the operative time, also observed 
by Gac, Cabane and Hou Shan Yao [19, 20]; performs safe sealing of blood vessels, observed 
Group 1 Group 2
Low pitched voice 3 4
Haematoma 2 4
Table 7. Complications in the two groups.
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also by Marazzo and Lepner [20, 21]. This device can also remove the complications regarding 
the thread pathology.
The extracapsular total complete thyroidectomy can be performed without isthmectomy.
Dissection of vascular pedicles is relatively easy, allowing sufficient exposure to a very nar-
row anatomical space, and the separation and preservation of the integrity of the laryngeal 
nerves and parathyroid glands are possible in the absence of invasion by the pathological 
process (tumor or inflammatory).
By lower temperature dispersion (1–2 mm) from the device’s jaws, the nerve elements are 
spared, detaching the thyroid by cutting the Berry ligaments and avoiding burns in the laryn-
geal tracheal conduit.
In order to avoid the possible thyroidectomy complications such as parathyroid trauma 
or laryngeal nerves injuries, a good hemostasis becomes the priority for the thyroid sur-
geons. Hemostasis achieved by classic methods such as tie and clamp, electrocautery, 
clips is time consuming and can lead to knot slipping and thermal trauma of the sur-
rounding tissues [22].
Nowadays, minimally invasive surgical techniques are used on a large scale in other surgical 
fields but thyroid gland resections, for both benign and malignant tumors are rarely per-
formed. Zorron et al. described an endoscopic approach in patients without preexisting neck 
operations using transoral-vestibular approach but with the limitation of the study due to the 
need of the evaluation of the technique [23].
8. Conclusion
Total and “complete” thyroidectomy represents a feasible technique in our days.
In our opinion, based on the results, this technique can be considered safe.
Using the vessel sealing devices brings real benefits both for patients and surgeons.
In surgical services that do not have assisted video surgery, this technique can be considered 
”gold standard” in selected cases.
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